Tamoxifen is widely prescribed for the treatment and prevention of estrogen receptor–positive breast cancer. This compound has an important role in constructing the side-chain structure that imparts receptor-binding selectivity and anti-estrogenic activity to Tamoxifen and related therapeutic agents. 4-(2-Piperidinoethoxy)benzoic acid hydrochloride is a key pharmaceutical intermediate employed to synthesize selective estrogen receptor modulators (SERMs), most notably Tamoxifen citrate.
4-(2-Piperidinoethoxy)benzoic acid hydrochloride
| CAS No | 84449-80-9 |
|---|---|
| Molecular Formula | C14H20ClNO3 |
| Molecular Weight | 285.76 g/mol |
| Synonyms | 4-(2-piperidin-1-ylethoxy)benzoic acid;hydrochloride |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
Tamoxifen is widely prescribed for the treatment and prevention of estrogen receptor–positive breast cancer. This compound has an important role in constructing the side-chain structure that imparts receptor-binding selectivity and anti-estrogenic activity to Tamoxifen and related therapeutic agents. 4-(2-Piperidinoethoxy)benzoic acid hydrochloride is a key pharmaceutical intermediate employed to synthesize selective estrogen receptor modulators (SERMs), most notably Tamoxifen citrate.
The CAS number of 4-(2-Piperidinoethoxy)benzoic acid hydrochloride is 84449-80-9.
The molecular formula of 4-(2-Piperidinoethoxy)benzoic acid hydrochloride is C14H20ClNO3.
The listed molecular weight of 4-(2-Piperidinoethoxy)benzoic acid hydrochloride is 285.76 g/mol.
The listed synonym or IUPAC name for 4-(2-Piperidinoethoxy)benzoic acid hydrochloride is 4-(2-piperidin-1-ylethoxy)benzoic acid;hydrochloride.